发明名称 Hepatitis C virus inhibitors
摘要 The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
申请公布号 US9303007(B2) 申请公布日期 2016.04.05
申请号 US201514806964 申请日期 2015.07.23
申请人 Bristol-Myers Squibb Company 发明人 Lopez Omar D.
分类号 C07D309/06 主分类号 C07D309/06
代理机构 代理人 Mingo Pamela A.
主权项 1. A compound which isor a pharmaceutically acceptable salt thereof.
地址 Princeton NJ US